San Diego Business Journal

Tease photo

Zogenix Getting a Heaping Dose of Criticism for Zohydro

PHARMA: Stock Takes Hit, But Co. Defends Painkiller

Zogenix Inc. is in damage control mode as it faces a maelstrom of criticism for its newly launched narcotic painkiller.

Fund Aims to Connect S.D. Biotech to China

Venture Capital: China’s Money, Manufacturing are Key

Lauded San Diego philanthropist Malin Burnham has teamed with Tom Gephart, an old-school venture capitalist, to launch a $200 million “Cross-Border Innovation Fund,” aiming to finance 10 to 20 startups with money largely from China.

Tease photo

Sorrento Therapeutics Creates Subsidiary to Focus on Animal Treatments

Sorrento Therapeutics Inc. (Nasdaq: SRNE), a maker of cancer and pain medications, has launched a new subsidiary called Ark Animal Therapeutics.

Medical Marijuana Inc. Relocates to Poway Complex

Medical Marijuana Inc., having outgrown its San Diego headquarters, is relocating to a multibuilding campus in Poway.

Tease photo

ATyr Pharma Inc. Appoints New CMO and a Director

ATyr Pharma Inc., a company that treats diseases of the immune system, has appointed biotech veteran David Weiner as its chief medical officer.

Tease photo

Barnes Leaving San Diego Post for a New Role With Kaiser

Mary Ann Barnes, executive director of Kaiser Permanente San Diego, is taking a new role at the health system – she’s been named regional president of Kaiser Permanente Hawaii Region.

Tease photo

Mary Ann Barnes Leaving San Diego Post for New Role With Kaiser

Mary Ann Barnes, executive director of Kaiser Permanente San Diego, is headed to the tropics to take on a new role at the health system – she’s been named regional president of Kaiser Permanente Hawaii Region.

La Jolla Biotech Company Targets China for Arthritis Drug Trials

RuiYi Inc., a biotechnology company split between La Jolla and Shanghai, has received $15 million in Series B financing from existing investors to further its uncommon business model.

Tease photo

New Drug ‘Pipeline’ Runs Under the Sea

BIOTECH: Sirenas Exploring Oceans to Find Possible Cures

Sirenas Marine Discovery Inc. is in an enviable position — it’s actually turning away investors as it turns to the ocean’s depths as a promising source for potential new drugs.

$1.4 Billion Settlement Proposed for San Onofre Closure

Southern California utility customers could see returns of $1.4 billion if a joint settlement related to last year’s shuttering of the San Onofre nuclear plant is approved.

Gary and Mary West Health Investment Fund Announces Sale of Sense4Baby Inc.'s Assets

The Gary and Mary West Health Investment Fund made a series of announcements – most notably that the assets of Sense4Baby Inc., its smartphone-based pregnancy monitoring company, have been acquired by San Antonio’s AirStrip Technologies LP.

RuiYi Receives $15M in Funding

RuiYi Inc., a biotech based both in La Jolla and Shanghai, has received $15 million in Series B financing from a group of existing investors.

Assay Depot Receives $3M in Series B Funding

Assay Depot Inc., Carlsbad’s self-dubbed “Amazon.com for scientists,” has landed $3 million in Series B funding.

SeniorQuote Insurance Services Completes $1.4M Funding Round

San Diego-based SeniorQuote Insurance Services Inc. has completed a $1.4 million Series A round.

Seragon Pharmaceuticals Names Former Onyx Pharmaceuticals CEO to its Board

Newly formed Seragon Pharmaceuticals Inc. has appointed N. Anthony Coles, the former CEO and board chairman of Onyx Pharmaceuticals Inc., to its board of directors.

Tease photo

Construction Complete on New UCSD Biomedical Research Facility

Construction is complete for the new, $113 million University of California, San Diego Health Sciences Biomedical Research Facility.

Construction Complete on UCSD Biomedical Research Facility

Construction is complete for the new, $113 million University of California, San Diego Health Sciences Biomedical Research Facility.

Congress Members, Researchers Push for More NIH Funding

U.S. Reps. Susan Davis and Scott Peters, both Democrats from San Diego, gathered with a group of the region’s medical research stakeholders to solicit Congress to increase funding for the National Institutes of Health, which funds much of the medical research taking place in this area.

Coalition Seeks to Curb Problem of Drug Theft at Open Houses

A coalition of businesses, nonprofits and San Diego real estate professionals has banded together to prevent prescription drug theft at open houses. Key to the group’s mission is ensuring the safe use, storage and disposal of prescription drugs.

Anaptys Lands Lucrative Development Deal

BIOTECH: Tesaro Will Develop 3 of Co.’s Drugs

AnaptysBio Inc., a player in the hot field of cancer immunotherapy, has attracted $17 million up front in a drug development rights deal with Massachusetts-based Tesaro Inc. that could ultimately be worth hundreds of millions more.

New Life Sciences Co. Ready to Buy Others

BIOTECH: No Narrow Niches For Maravai and Local CEO

Chicago private equity firm GTCR is doling out up to $300 million to launch Maravai Life Sciences Inc. in San Diego, tapping the expertise of former Gen-Probe Inc. executives Carl Hull and Eric Tardif to lead a new, acquisition-driven venture.

Richard Branson to Be Keynote Speaker at Biotech Convention Set for San Diego

Billionaire Virgin Group founder Richard Branson will be the keynote speaker at the 2014 Bio International Convention in San Diego — one of the nation’s largest biotechnology forums that attracts more than 15,000 attendees each year.

Tease photo

AMN Healthcare Investing in Telepharmacy Company

San Diego staffing firm AMN Healthcare Services Inc. will invest $5 million in a series of staged payments to San Francisco telepharmacy company PipelineRx.

Tease photo

Mallinckrodt Completes Acquisition of Cadence Pharmaceuticals

Irish specialty drugmaker Mallinckrodt PLC has completed the $1.4 billion purchase of San Diego-based Cadence Pharmaceuticals Inc. The deal was announced initially in February.

New Private Equity-Backed Company Ready to Acquire Life Sciences Firms

Former Gen-Probe executives Carl Hull and Eric Tardif have been tasked by a Chicago-based private equity firm to launch a life sciences company in San Diego aimed at acquiring other companies and with a few hundred million dollars at the ready.

Tease photo

U.S. Reps from San Diego Urge Increase in NIH Funding

U.S. Reps. Susan Davis and Scott Peters, both Democrats from San Diego, gathered with a group of the region’s medical research stakeholders to solicit Congress to increase funding for the National Institutes of Health, which funds much of the medical research taking place in this area.

Tease photo

New Kaiser Medical Office Building to Open

Kaiser Permanente will open a new medical office building in Oceanside on March 17.

AnaptysBio Inc. Partnership Deal Could Be Worth $125M

AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront

AnaptysBio Inc. Deal Could Be Worth $125 Million

AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront.

Zogenix’s Powerful Painkiller Faces Attacks From Two Fronts

Things aren’t looking great for Zogenix Inc. nor its flagship drug, the powerful narcotic painkiller Zohydro. The company’s stock recently plummeted on news that a competitor just might have built a better mousetrap — drug — and could soon emerge on the market.

Tease photo

Experience With Illness Is Catalyst for Creating New Business

BIOTECH: Proactive Patient Got to Work on New Mobility Device

Extreme athlete Kim Goodsell has a bevy of health conditions that could severely limit her ability to walk. But with research, ingenuity and sheer pluck she has taken charge of her own health — and launched a new company as a result.

Lumena Nabs $45M in Financing to Continue Developing 2 Drugs

Pharma: Mid-Stage Trials Completed After Company Bought Rights From Pfizer

Fast-moving Lumena Pharmaceuticals Inc. has secured $45 million in Series B financing. The company will use the funding to develop drugs for two diseases of the liver — one rare and lacking in treatment options, the other a disorder that’s expanding in prevalence and market potential.

Tease photo

Veteran Exec Smooths Life Tech’s Transition

BIOTECH: Stevenson Is President of New Division

Shepherding thousands of employees through a high-profile merger is highly daunting, but Mark Stevenson considers himself equal to the task. The veteran biotech executive has, after all, done it before.

Tease photo

DJO Global Appoints New CFO

Vista-based medical device maker DJO Global Inc. has appointed Susan Crawford as the company’s new chief financial officer.

PatientSafe Receives $3M Investment From a Canadian Telecom Company

San Diego-based mobile health care software developer PatientSafe Solutions Inc. has received a $3 million investment from Telus Ventures, the investment arm of Canadian telecom giant Telus Communications Co. (TSE: T).

Tease photo

Lumena Pharmaceuticals Closes $45M Funding Round

Lumena Pharmaceuticals Inc. has closed a $45 million Series B round, and will use the funding to develop drugs for two diseases of the liver.

Sharp HealthCare Names New Chief Information Officer

Sharp HealthCare has named Ken Lawonn as its new chief information officer. He is replacing Bill Spooner, who retired March 3 after working 35 years for Sharp.

Tease photo

Illumina Sells Another $10M Gene Sequencer

San Diego-based Illumina Inc. has another buyer for its $10 million gene sequencing platform.

Tease photo

DJO Global Taps Former IMDS CEO to Head DJO Surgical Brand

DJO Global Inc. has appointed Brady Shirley, an executive in the orthopedics industry, as president of its DJO Surgical brand.

Valor Fined $250,000 for Withholding Test Results from FDA

Medical: Founder and Employees Also Admit Responsibility for Omissions

Valor Medical Inc. has been fined $250,000 for intentionally withholding from the Food and Drug Administration unfavorable test results indicating the toxicity of its brain aneurism treatment — an offense that Assistant U.S. Attorney Melanie Pierson said was “perpetrated for the purpose of commercial profit.”

Tease photo

DJO Global Taps Former IMDS CEO to Head DJO Surgical Brand

DJO Global Inc. has appointed Brady Shirley, an executive in the orthopedics industry, as president of its DJO Surgical brand.

New Co. Looks to Extend Our Expiration Dates

BIOTECH: Venter Envisions Shift to Preventive Medicine Through Genomics Research

San Diego super scientist J. Craig Venter has launched a new company, Human Longevity Inc., with an ambitious — albeit ambiguous — pursuit: make people live longer.

Celgene Support Gives Abide Therapeutics $50M

BIOTECH: Enzymes Are Targeted to Treat A Variety of Conditions

San Diego-based Abide Therapeutics Inc. has partnered with biotech titan Celgene Corp. to develop new drugs in inflammation and immunology, receiving $50 million upfront in the deal.

Tease photo

The Good, The Bad: The Generics

PHARMA: Patient Benefits, Patent Lawsuits Are All Part of the Mix

Adamis Pharmaceuticals Corp. stands unique among San Diego’s many drugmakers: It’s going generic.

Emotient Inc. Closes $6M Funding Round

San Diego-based Emotient Inc., a maker of facial expression recognition software, has closed a $6 million Series B round of funding, led by Silicon Valley venture firm Handbag LLC.

Scripps Health Breaks Ground on $175M Medical Office Building

Scripps Health broke ground on its new, $175 million medical office building at Scripps Memorial Hospital La Jolla – part of a $2 billion renovation plan for the campus.

Tease photo

Sequenom Announces Leadership Changes, New CEO

Genetic testing company Sequenom Inc. is shaking up its leadership with a number of internal promotions.

Acadia Prices Public Offering of Common Stock

Acadia Pharmaceuticals Inc. announced it plans to raise $182 million in a secondary public offering of its common stock, pricing 6.4 million shares at $28.50 apiece.

J. Craig Venter Part of Team Launching Human Longevity Inc.

San Diego super-scientist J. Craig Venter has launched a new company, Human Longevity Inc. that aims to prolong the human lifespan through genomics and cell therapy-based diagnostics.

Tease photo

Connect Appoints New CEO

Connect, a San Diego life sciences and technology nonprofit, has appointed veteran health care and investment banking executive Greg McKee as its new CEO.